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Abstract
Introduction: Brucellosis is a zoonosis with worldwide distribution, which is particularly endemic in many countries
of the Mediterranean basin. Cardiovascular complications of this disease, such as endocarditis, myocarditis and
pericarditis, are very rare, with even fewer cases of myocarditis or asymptomatic pericardial effusion in the absence
of concomitant endocarditis being reported.
Case presentation: We report two cases of brucellosis in two Caucasian men, aged 17 and 34 years old, with
myocarditis and asymptomatic pericardial effusion, respectively. Of note, neither patient had concomitant
endocarditis. The disease was confirmed serologically and by blood cultures. Both patients recovered completely
after receiving appropriate antibiotic treatment without any sign of relapse during a follow-up of 12 months.
Conclusion: These two cases emphasize that in endemic areas Brucella can be considered as a potentially
causative agent of idiopathic pericardial effusion or myocarditis, even in the absence of concomitant endocarditis.
This possibility could be taken into account particularly in cases where contraction of brucellosis is possible, such
as occupational exposure or consumption of unpasteurized dairy products.
Introduction
Brucellosis is a worldwide zoonosis, with the Mediterra-
nean basin, the Middle East, India, Mexico, and Central
and South America being the most affected areas [1].
The disease has generalized and systemic symptoms,
and almost every organ of the human body can be
affected by Brucella. Despite this, the incidence of cardi-
ovascular complications in brucellosis, such as endocar-
ditis, myocarditis or pericarditis, is reported to be as low
of 1% of cases [1,2], with even fewer cases of myocardi-
tis or pericarditis in the absence of concomitant endo-
carditis being reported. Indeed, myocarditis, pericarditis
or asymptomatic pericardial effusion in brucellosis is
thought to develop almost exclusively in the presence of
endocarditis [1,2]. We report two cases of patients, one
with asymptomatic pericardial effusion and the other
myocarditis caused by brucellosis in the absence of
concomitant endocarditis. These unusual features of
brucellosis may be underestimated components of the
disease.
Case presentations
Patient 1
A 34-year-old Caucasian man was admitted our hospital
with malaise, fatigue, and low-grade fever (up to 38°C),
and a two-month history of rigors. He also reported
anorexia and weight loss, night sweats, and generalized
arthralgia. His medical history was non-contributory. He
worked as a food handler.
On physical examination, the only abnormalities were
a systolic murmur (grade II/VI) of the heart and hepa-
tosplenomegaly. Laboratory investigations revealed low
haemoglobin 11.6 g/dL (normal range 13.0-18.0 g/dL),
and raised aspartate aminotransferase (57 U/L; upper
normal limit (UNL) 40 U/L), alaninoaminotransferase
(57 U/L; UNL: 40 U/L) and gamma-glutamyl transpepti-
dase (55 U/L; UNL 37 U/L). Electrocardiography (ECG)
was normal with sinus rhythm, but chest radiography
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tures, and investigations for Epstein-Barr virus (EBV),
cytomegalovirus, enteric cytopathic human orphan
(ECHO) virus, coxsackie viruses, herpes simplex virus
(HSV), varicella-zoster virus (VSV), adenovirus, Coxiella
burnetti, Chlamydia pneumoniae, Leptospira spp. and
Mycoplasma pneumoniae were negative. However, serum
agglutination tests were positive (titre >1:2560), and
enzyme-linked immunosorbent assay (SERION ELISA
Classic IgG/IgM; Institute Virion/Serion GmbH, Wurz-
burg, Germany) tests for anti-Brucella IgG and IgM anti-
b o d i e sw e r es t r o n g l yp o s i t i v e( 1 1 8U / m la n d3 5 . 5U / m l ;
UNL 30 U/ml and 20 U/ml, respectively). In addition, Bru-
cella spp. were isolated from consecutive blood cultures
(six out of eight cultures positive). Two-dimensional trans-
thoracic and trans-oesophageal echocardiography was
performed to investigate for the possible presence of Bru-
cella-related endocarditis because of our patient’s systolic
heart murmur, six positive blood cultures and presence of
cardiomegaly on chest radiographs. The investigation
showed normal valves without any sign of vegetation;
however, there was marked pericardial effusion without
signs of cardiac tamponade, even though our patient had
not reported any chest pain.
Additional extensive laboratory blood tests were per-
formed because of the asymptomatic pericardial effusion,
including tumor markers, C-reactive protein, fibrinogen,
rheumatoid factor, antinuclear antibodies, anti-double-
stranded DNA antibodies, serum immunoglobulins, and
C3 and C4 component, but did not reveal the cause.
There were no clinical or radiologic signs (computed
tomography and MRI scans) suggestive for the presence
of spondylitis, splenic disease or epididymoorchitis.
Accordingly, a diagnosis of Brucella-related asympto-
matic pericardial effusion in the absence of concomitant
endocarditis was made and specific treatment with anti-
biotics only was started immediately. Our patient was
given oral doxycycline 100 mg twice daily plus oral rifam-
picin 900 mg once daily for three months, with intramus-
cular streptomycin 1 g once daily for the first three
weeks. Our patient attended for treatment and follow-up
to our outpatient clinic every two weeks. His symptoms
regressed rapidly 10 days after initiation of treatment,
and no recurrence or adverse drug reactions were
observed during follow-up (to one year from the begin-
ning of therapy). Echocardiographic studies three, six and
12 months after the start of treatment showed no peri-
cardial effusion. When last seen, 12 months after starting
therapy, our patient was well with no sign of relapse.
Patient 2
A 17-year-old Caucasian man was admitted to our hos-
pital with a six-day history of high-grade fever (up to
39°C) and chest pain. He also reported fatigue, anorexia,
generalized arthralgia, headache and night sweats. He
had been treated with paracetamol by his general practi-
tioner for an upper respiratory infection, but the symp-
toms remained and worsened. He was living in a rural
area of central Greece and was working as a stock
farmer. His medical history was unremarkable.
On physical examination, only tachypnoea and hepa-
tosplenomegaly were seen. ECG demonstrated repolari-
zation disturbances with T-wave inversion in the II, III,
aVF and V2 to V6 leads.
Laboratory investigations found a raised white blood
cell count of 11.15 x 10
9/l (normal range 4-11 x 10
9/L),
creatine phosphokinase 305 IU/L (30-190 IU/L) and lac-
tate dehydrogenase 247 IU/L (12-230 IU/L). Results of
the remaining haematological and biochemical tests,
including liver function tests, were within normal
ranges. A qualitative determination of troponin was
positive, which was confirmed by a quantitative method.
A diagnosis of myocarditis due to an infectious agent
was suspected because of the history of chest pain in
association with the positive troponin test and the ECG
abnormalities. Two-dimensional trans-thoracic and
trans-oesophageal echocardiography revealed a mild
regional motion abnormality of the left ventricular wall
but without pericardial effusion or valves vegetations.
Blood, urine, and pharynx cultures were negative, as
were serology tests for Influenza A and B, parvovirus,
EBV, CMV, ECHO virus, coxsackie virus, HSV, VSV,
adenovirus, Coxiella burnetti, Chlamydia pneumonia,
Leptospira, Mycoplasma pneumonia.H o w e v e r ,s e r u m
agglutination tests were positive at a titre >1:1280 and
ELISA results for anti-Brucella IgG and IgM antibodies
were strongly positive (92 U/ml and 48 U/ml, antibo-
dies, respectively), and Brucella spp was isolated in two
out of four sets of blood cultures. As for patient 1, there
were no clinical and radiologic signs suggestive for the
presence of other systemic features of the disease.
Accordingly, a diagnosis of Brucella-related myocardi-
tis was made and our patient was treated only with the
specific triple antibiotic regimen as for patient 1 (oral
doxycycline 100 mg twice daily plus oral rifampicin 900
mg once daily for three months, with intramuscular
streptomycin 1 g once daily for the first three weeks).
His symptoms regressed rapidly after initiation of treat-
ment. His echocardiographic and ECG studies three and
12 months after the start of treatment were completely
normal, and he showed no signs of relapse during
12 months of follow-up at our outpatient clinic.
Discussion
Brucellosis is still highly prevalent in countries of the
Mediterranean basin including Greece [1,3-5]. Based on
the well-known routes of transmission, brucellosis has
long been considered an occupational disease affecting
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dairy-industry professionals, and personnel in microbio-
logic laboratories [1,4-6]. The clinical features of the dis-
ease include splenomegaly, joint involvement presenting
as arthritis or spondylodiscitis, lymphadenopathy, lung
or liver involvement, and orchitis or epididymoorchitis
[1,7-9].
Cardiovascular complications of brucellosis (endocardi-
tis, myocarditis and pericarditis) are rare. In cases of endo-
carditis, which is the most common cardiovascular
involvement of the disease, the aortic valve and less fre-
quently the mitral valve are affected. No good response to
medical therapy has been observed, and there is poor
prognosis without surgery [10]. Replacement of the
affected valve is almost always necessary after five to seven
days of antibiotic therapy [10]. In these cases, the develop-
ment of pericardial effusion or myocarditis is common.
However, in the absence of concomitant Brucella-related
endocarditis, development of pericardial effusion and/or
myocarditis seems to be extremely rare [1,2,11-18].
Indeed, when we searched in the MEDLINE database for
articles published between 1984 and 2010 using the words
‘pericarditis’, ‘myocarditis’ and ‘brucellosis’,w ei d e n t i f i e d
only 11 reports in the English literature of adult patients
with brucellosis including 14 patients with appropriate
information for analysis on brucellosis-related pericarditis
or myocarditis in the absence of concomitant endocarditis
[2,12,14,17,19-25] (Table 1). In addition, pericarditis or
myocarditis was not reported in any recently reported
cases (>200) of brucellosis [1,13]. In another study from
Spain (Malaga), it was reported that only 1.5% of 530 bru-
cellosis cases had cardiac involvement, with only one
patient with pericarditis and one with myocarditis (0.2%)
in the absence of concomitant endocarditis (Table 1) [2].
In a prospective study of 400 cases from Kuwait, only two
cases with endocarditis and an additional six cases of
other cardiovascular complications (including one case of
myocarditis) were reported (Table 1) [19]. Lubani et al.
[26] reported three more cases of Brucella myocarditis in
a series of 200 children with brucellosis, and myocarditis
has also been described in a case of disseminated brucello-
sis with multiple organ involvement [20].
In our first patient, the general symptoms were predo-
minant and, contrary to other reports [12,14,24], the
pericardial effusion was asymptomatic. This suggests
that this unusual feature could be underestimated if
echocardiography is not in routine use. However, both
patients showed evidence of cardiac involvement on
routine tests (chest radiography in the first and ECG in
the second case) making the value of routine use of
echocardiography in suspected cases of brucellosis
questionable.
The cardiac damage may be due to a direct effect of
the microorganism as suggested by pericardial fluid
cultures [12], or by local deposit of immunocomplexes
as seen in cardiac biopsies. In this context, the role of
delayed diagnosis, as in our first patient, in the develop-
ment of cardiovascular complications of brucellosis may
deserve further evaluation. The diagnosis is based on
the demographic and epidemiologic characteristics of
the disease, the presence of symptoms, results of serolo-
gical tests, isolation of the microorganism by blood or
bone marrow cultures, and exclusion of other possible
causes of pericardial effusion and myocarditis. Pericar-
diocentesis and heart biopsy remain the techniques
of choice for supporting a definite diagnosis of Brucella-
related involvement of the heart, but these interven-
tional investigations are not easily performed for
diagnosis in routine clinical practice and add no addi-
tional information when a safe diagnosis has already
been made by other means.
We treated both our patients with triple antibiotic
therapy only (without non-steroidal anti-inflammatory
drugs or prednisolone). The response was complete in
both, with no signs of relapses during the follow-up per-
iod. Although endocarditis was not found, both patients
received treatment for three months because we believe
that cardiac involvement (ev e ni nt h ea b s e n c eo fe n d o -
carditis) along with repetitive positive blood cultures
cannot be safely considered an uncomplicated form of
the disease while we lack evidence-based data from
large prospective studies on the treatment of cardiovas-
cular features of this disease in the absence of concomi-
tant endocarditis.
Conclusion
These cases further emphasize that Brucella can affect
every organ and system of the human body [1,8,9,27,28].
The prevalence of involvement of the pericardium or
myocardium in the absence of concomitant endocarditis
in brucellosis may be underestimated because thorough
echocardiographic studies in patients with brucellosis
are lacking. However, both our patients showed evi-
dence of cardiac involvement on routine tests and there-
fore, use of these tests seems to be essential in the
assessment of febrile patients, especially where brucello-
sis is clinically and epidemiologically suspected. Echo-
cardiography can be then used if such abnormalities are
detected on routine tests. Nevertheless, we believe that
in areas where the disease is endemic, it is reasonable to
include brucellosis in the differential diagnosis of disor-
ders that affect the pericardium or myocardium even in
the absence of concomitant endocarditis, although large
prospective echocardiographic studies in established
brucellosis cases are needed in an attempt to definitively
address the precise prevalence of cardiac complications
of brucellosis. We are currently undertaking such
studies.
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Written informed consent was obtained from the
patients for publication of these case reports. A copy of
the written consent is available for review by the Editor-
in-Chief of this journal.
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